Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
News, developments and strategies related to eClinical, data management, data collection, ePRO, and more information technology used in the drug development chain. Go→
News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→
|
|
Atypical Brain Circuits May Cause Slower Gaze Shifting In Infants Who Later Develop Autism
Publish date: Mar 20, 2013
![]()
PR Newswire PHILADELPHIA, March 20, 2013
PHILADELPHIA, March 20, 2013 /PRNewswire-USNewswire/ -- Children
who are later diagnosed with autism have subtle but measurable differences in attention as early as 7 months of age, finds
a study published today in the American Journal of Psychiatry. Researchers found that infants who went on to be diagnosed
with autism are slower to shift their gaze from one object to another, compared to peers who did not receive the diagnosis.
The scientists also identified specific brain circuits that seem to cause the slower response. The findings point to a problem
with "sticky attention", a phenomenon observed in preschool and older children with autism, but not well studied before in
babies at risk for autism. The study was conducted by the Infant Brain Imaging Study (IBIS) Network, which includes researchers at the Center for
Autism Research at The Children's Hospital of Philadelphia. "This is a very exciting study, because the impairments in shifting gaze and attention that we found in 7-month-olds may
be a fundamental problem in autism," said Robert T. Schultz, Ph.D. Director of the Center for
Autism Research at CHOP and a co-author on the study. "These results are another piece of the puzzle in pinpointing the earliest
signs of autism. Understanding how autism begins and unfolds in the first years of life will pave the way for more effective
interventions and better long-term outcomes for individuals with autism and their families." These findings suggest that 7-month-olds who go on to develop autism show subtle, yet overt, behavioral differences prior
to the emergence of autism spectrum disorder (ASD). They were slower than both high-risk-negative and low-risk infants to
orient or shift their gaze to objects that appeared outside their direct gaze (by approximately 50 millisceconds). Results
also implicate a specific neural circuit (the splenium of the corpus callosum), which may develop differently in those at
risk for ASD compared to typically developing infants, who show more rapid orienting to visual stimuli. The study concluded
that atypical visual orienting is an early feature of later emerging ASD and is associated with a deficit in a specific neural
circuit in the brain. The study included 97 infants: 16 high-risk infants later classified with an ASD, 40 high-risk infants not meeting ASD
criteria (i.e., high-risk-negative) and 41 low-risk infants. For this study, infants participated in an eye-tracking test
and a brain scan at 7 months of age and a clinical assessment at 25 months of age. The IBIS Network consists of research sites at UNC, The Children's Hospital of Philadelphia,
Washington University in St. Louis, the University
of Washington in Seattle, the University of Utah in Salt Lake
City, and the Montreal Neurological Institute at McGill University, and is currently recruiting
younger siblings of children with autism and their families for ongoing research. Funding support for the study was provided
by the National Institutes of Health, Autism Speaks and the Simons Foundation Autism Research Initiative. IMAGES AVAILABLE UPON REQUEST RELATED LINKS Media Contacts: This news release was issued on behalf of Newswise™. For more information, visit http://www.newswise.com
.
SOURCE The Children's Hospital of Philadelphia
|
|